Generex Biotechnology Announces Record & Payment Dates for 20:1 Stock Dividend

Generex Biotechnology Announces Record & Payment Dates for 20:1 Stock Dividend


MIRAMAR, Fla.-- --Oct 31, 2018--Generex Biotechnology Corporation today announced that the Record Date for the determination of the holders of the Company's common stock entitled to participate in the Company's previously announced 20:1 common stock dividend will be Monday, November 5, 2018. The dividend Payment Date will be Tuesday, November 13, 2018.



from Biotech News
Share:

Bristol-Myers Squibb Co (BMY) Holdings Trimmed by Cullen Frost Bankers Inc.

Bristol-Myers Squibb Co (BMY) Holdings Trimmed by Cullen Frost Bankers Inc.


Cullen Frost Bankers Inc. lowered its stake in shares of Bristol-Myers Squibb Co by 23.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 97,860 shares of the biopharmaceutical company's stock after selling 30,261 shares during the period.



from Biotech News
Share:

Origins of RWJ University Hospital and other tidbits of N.J. history | Albright

Origins of RWJ University Hospital and other tidbits of N.J. history | Albright


Founded as the New Brunswick City Hospital in 1884, Robert Wood Johnson University Hospital today is the flagship facility of the RWJBarnabas Health system. The hospital changed its name in 1889 to the John Wells Memorial Hospital when Grace Tileston Wells, a community leader, donated a building in honor of her late husband, John Wells.



from Biotech News
Share:

Body Mass Index associated with deaths from most causes

Body Mass Index associated with deaths from most causes


Led by the London School of Hygiene & Tropical Medicine and funded by the Wellcome Trust and the Royal Society, the research suggests a BMI of between 21-25kg/m2 is associated with the lowest risk of dying from cancer and heart disease. The study is one of the largest studies of its kind to look at how BMI is associated with the risk of death both overall, and from a full spectrum of different causes-3.6 million people and 367,512 deaths were included in the analysis.



from Biotech News
Share:

Finanzen: Freiwillig GKV versichert : Freiwillig gesetzlich krankenversichert

Niemand muss sich privat krankenversichern. Das gilt auch, wenn die Pflichtversicherung in der gesetzlichen Kasse endet. Wer sich freiwillig versichert, zahlt oft höhere Mindestbeiträge als Pflichtversicherte.

from Finanztip Feed
Supported by Video Collection
Share:

Big biotech companies have flushed $100 billion in stock buybacks down the toilet

Big biotech companies have flushed $100 billion in stock buybacks down the toilet


When it comes to the more than $100 billion that big biotech companies have spent in recent years, Leerink analyst Geoffrey Porges might well sing back: Absolutely nothing. , among others, have actually produced a negative rate of return on their stock buybacks, though they were also able to influence earnings-per-share growth in the process.



from Biotech News
Share:

Former Genentech workers charged with giving confidential drug

Former Genentech workers charged with giving confidential drug


Four former Genentech employees have been charged with stealing secret drug formulas from the South San Francisco biotechnology firm and delivering them to a company in Taiwan. Four former Genentech employees have been charged with stealing secret drug formulas from the South San Francisco biotechnology firm and delivering them to a company in Taiwan.



from Biotech News
Share:

firma.de und Commerzbank starten bundesweite Kooperation für Gründer

firma.de und Commerzbank starten bundesweite Kooperation für Gründer


image description
Gründer können ab Oktober 2018 von der bundesweiten Kooperation zwischen firma.de und Commerzbank profitieren. Diese ermöglicht einen optimierten Online-Gründungsprozess, der den notwendigen Schritt der Geschäftskontoeröffnung wesentlich vereinfacht. Optimierter Gründungsprozess für alle Rechtsforme...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Long-lasting HIV injection is a step closer after second GSK study

Long-lasting HIV injection is a step closer after second GSK study


A once-monthly injection to control HIV proved as effective as daily pills in a second study by GlaxoSmithKline, paving the way for a new regimen that could be simpler for some patients to be filed with regulators. The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018.



from Biotech News
Share:

Pfizer cuts revenue forecast as supply snags, dollar strength weigh

Pfizer cuts revenue forecast as supply snags, dollar strength weigh


U.S. drugmaker Pfizer Inc's third-quarter profit rose nearly 45 percent, driven by lower tax rates and higher sales of breast cancer drug Ibrance and pneumonia vaccine Prevnar. FILE PHOTO: A logo of American pharmaceutical corporation Pfizer Inc., is pictured in Toluca, Mexico October 1, 2018.



from Biotech News
Share:

Pfizer tops expectations for the quarter

Pfizer tops expectations for the quarter


This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Oct. 30, 2018.



from Biotech News
Share:

Pfizer's 3Q profit, up due to tax cut, beats expectations

Pfizer's 3Q profit, up due to tax cut, beats expectations


This Dec. 4, 2017, file photo shows a tablet of Pfizer's Viagra, left, and the company's generic version, sildenafil citrate, at Pfizer Inc., headquarters in New York. Pfizer Inc. reports earnings Tuesday, Oct. 30, 2018.



from Biotech News
Share:

Cantor Fitzgerald Analysts Give BioDelivery Sciences International (BDSI) a $5.00 Price Target

Cantor Fitzgerald Analysts Give BioDelivery Sciences International (BDSI) a $5.00 Price Target


The brokerage currently has a buy rating on the specialty pharmaceutical company's stock. Other analysts have also recently issued research reports about the stock.



from Biotech News
Share:

"Pilze" und "Bürsten" helfen, krebsbekämpfenden Nanopartikeln im Körper zu überleben

"Pilze" und "Bürsten" helfen, krebsbekämpfenden Nanopartikeln im Körper zu überleben


image description
Bei einer Reihe von innovativen und lebensrettenden medizinischen Behandlungen, von Organersatz und Hauttransplantationen bis hin zur Krebstherapie und Chirurgie, hängt der Erfolg oft davon ab, dass man vorbeikommt oder das Immunsystem des Körpers abwehrt. In einer neuen Entwicklung, die auf die Unt...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Stolen inflatable colon recovered, Kansas City police say Source: Cox Media Group

Stolen inflatable colon recovered, Kansas City police say Source: Cox Media Group


Update 5:31 p.m. EDT Oct. 29: In a tweet , the Kansas City Police Department said it has recovered the inflatable colon that was stolen earlier this month. The department said a tip led officers to a vacant house in Kansas City, where the 10-foot, 150-pound inflatable replica of a colon was found.



from Biotech News
Share:

Narcan to be offered to all YMCAs, public libraries across the country

Narcan to be offered to all YMCAs, public libraries across the country


The availability of Narcan is growing. The nasal spray is now being offered to all public libraries and YMCAs across the country.



from Biotech News
Share:

Brainstorm Cell Therapeutics (BCLI) Given a $9.00 Price Target at Maxim Group

Brainstorm Cell Therapeutics (BCLI) Given a $9.00 Price Target at Maxim Group


The brokerage currently has a "buy" rating on the biotechnology company's stock. Maxim Group's price target suggests a potential upside of 171.08% from the company's previous close.



from Biotech News
Share:

WACKER benennt neu erworbene Pharmaprotein-Produktion um

WACKER benennt neu erworbene Pharmaprotein-Produktion um


Wacker Biotech B.V. – so heißt ab 1. November 2018 die Pharmaprotein-Produktion in den Niederlanden, die WACKER mit der Akquisition von SynCo Bio Partners Luxembourg S.à r.l. übernommen hat. Im April 2018 hatte WACKER den Standort in Amsterdam zur Herstellung von Biopharmazeutika, Lebendbakterien un...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Shionogi aims to double flu-drug market with FDA-approved treatment

Shionogi aims to double flu-drug market with FDA-approved treatment


Japan's Shionogi & Co Ltd aims to double the global market for flu treatment with its drug Xofluza, the first flu drug approved by the U.S. Food and Drug Administration agency in nearly 20 years, its chief executive said. The drugmaker on Monday raised its full-year operating profit outlook to 124.5 billion yen , underpinned by an early approval for the new drug, beating the average market estimates of 121.08 billion yen, according to Refinitiv.



from Biotech News
Share:

Milestone Pharmaceuticals meldet 80 Millionen Dollar private Finanzierung

Milestone Pharmaceuticals meldet 80 Millionen Dollar private Finanzierung


Milestone Pharmaceuticals, ein biopharmazeutisches Unternehmen, das Therapien für Tachykardien entwickelt, gab den Abschluss einer privaten Finanzierung in Höhe von 80 Millionen US-Dollar bekannt. Die Eigenkapitalfinanzierung umfasste die Beteiligung neuer und bestehender institutioneller Investoren...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis forscht zusammen mit Pfizer an der Lebererkrankung NASH

Novartis forscht zusammen mit Pfizer an der Lebererkrankung NASH


(dpa-AFX) Der beiden Pharmakonzerne Novartis und Pfizer wollen künftig gemeinsam an der Lebererkrankung NASH forschen und nach Behandlungsmethoden suchen. Das teilten die Konzerne am Montag mit, Angaben über finanzielle Details wurden nicht gemacht. Zur Behandlung der nicht-alkoholischer Steatohepat...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

[Podcast] Talking Biotech Ingredients with Christina Agapakis

[Podcast] Talking Biotech Ingredients with Christina Agapakis


This is just part of the article. Want the complete story, plus a host of other cutting-edge technical and business articles to make your job easier? Login or Register for free! In the latest episode of the Two Sense Podcast, Perfumer & Flavorist sat down with Christina Agapakis , creative director of Ginkgo Bioworks and Flavorcon presenter, to discuss everything biotechnology.



from Biotech News
Share:

Contrasting Oncolytics Biotech (ONCYF) and Its Competitors

Contrasting Oncolytics Biotech (ONCYF) and Its Competitors


Oncolytics Biotech is one of 525 publicly-traded companies in the "Pharmaceutical preparations" industry, but how does it compare to its rivals? We will compare Oncolytics Biotech to related businesses based on the strength of its profitability, valuation, analyst recommendations, dividends, earnings, risk and institutional ownership. Oncolytics Biotech has a beta of 1.62, indicating that its share price is 62% more volatile than the S&P 500.



from Biotech News
Share:

Novartis, Pfizer join forces on potentially lucrative fatty liver disease

Novartis, Pfizer join forces on potentially lucrative fatty liver disease


Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics. FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017.



from Biotech News
Share:

State Treasurer State of Michigan Acquires 2,300 Shares of Bristol-Myers Squibb Co

State Treasurer State of Michigan Acquires 2,300 Shares of Bristol-Myers Squibb Co


State Treasurer State of Michigan grew its holdings in shares of Bristol-Myers Squibb Co by 0.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 752,917 shares of the biopharmaceutical company's stock after purchasing an additional 2,300 shares during the quarter.



from Biotech News
Share:

Traynor Capital Management Inc. Boosts Holdings in Amgen, Inc.

Traynor Capital Management Inc. Boosts Holdings in Amgen, Inc.


Traynor Capital Management Inc. raised its stake in Amgen, Inc. by 8.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,408 shares of the medical research company's stock after buying an additional 855 shares during the period.



from Biotech News
Share:

Neue Ära im Kampf gegen Krebs

Neue Ära im Kampf gegen Krebs


image description
Es ist nicht weniger als eine Revolution: Erstmals sind in Europa Krebs-Therapien mit genetisch veränderten Körperzellen zugelassen. Das Verfahren gilt als bahnbrechend und könnte auf lange Sicht das vielversprechendste Mittel gegen Krebs sein. CA-was? CAR-T steht für „chimärer Antigenrezeptor-T-Zel...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Did the CDC really warn people against dressing chickens up for Halloween?

Did the CDC really warn people against dressing chickens up for Halloween?


This October, media outlets across the nation warned that chicken owners should not dress their feathered friends in costumes for Halloween. The warning came straight from the Centers for Disease Control and Prevention, according to the reports that were spread across social media.



from Biotech News
Share:

Healthcare stocks lead broad ASX rebound

Healthcare stocks lead broad ASX rebound


Australian shares have rebounded from 12-month lows touched in the back end of last week, with every sector on the benchmark index closing in the black on Monday. The S&P/ASX 200 Index closed 63 points, or 1.1 per cent, higher at 5728.2, while the broader All Ordinaries rose 54.2 points, or 0.9 per cent, to 5813.8. "Having fallen roughly 11 per cent from their August high, Australian shares had become technically oversold and due for a bounce," said AMP Capital chief economist Shane Oliver.



from Biotech News
Share:

Wiederholte Interferonstimulation schafft natürliches Immungedächtnis

Wiederholte Interferonstimulation schafft natürliches Immungedächtnis


image description
Das angeborene Immunsystem kann trainiert werden, um auf Virusinfektionen effizienter zu reagieren, indem es wiederholt antiviralen Signalmolekülen ausgesetzt wird.Säugetierzellen scheinen in der Lage zu sein, sich die antivirale Stimulation auf der Ebene der DNA-packenden Moleküle zu merken, was ei...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Zellen mit Raman-Mikroskopie auf Resistenzen gegen Krebsmedikamente testen

Zellen mit Raman-Mikroskopie auf Resistenzen gegen Krebsmedikamente testen


image description
Herkömmliche Methoden basieren auf Antikörpern oder Markern. Das neue Verfahren kommt ohne solche Zusätze aus. Biophysiker der Ruhr-Universität Bochum (RUB) haben gezeigt, dass sich mit der Raman-Mikroskopie Resistenzen von Tumorzellen gegen Krebsmedikamente nachweisen lassen. Anders als herkömmlich...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Dynamic Advisor Solutions LLC Lowers Stake in Pfizer Inc.

Dynamic Advisor Solutions LLC Lowers Stake in Pfizer Inc.


Dynamic Advisor Solutions LLC cut its holdings in shares of Pfizer Inc. by 5.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,962 shares of the biopharmaceutical company's stock after selling 2,371 shares during the period.



from Biotech News
Share:

Comparing Tecogen

Comparing Tecogen


Tecogen and Notis Global are both small-cap construction companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Tecogen has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500.



from Biotech News
Share:

Head to Head Contrast: Meridian Bioscience

Head to Head Contrast: Meridian Bioscience


Meridian Bioscience and Response Genetics are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. 88.1% of Meridian Bioscience shares are owned by institutional investors.



from Biotech News
Share:

Contrasting Cyanotech

Contrasting Cyanotech


Cyanotech and Cronos Group are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. 16.7% of Cyanotech shares are owned by institutional investors.



from Biotech News
Share:

Oppenheimer & Co. Inc. Sells 1,746 Shares of SPDR S&P Biotech Etf

Oppenheimer & Co. Inc. Sells 1,746 Shares of SPDR S&P Biotech Etf


Oppenheimer & Co. Inc. lowered its position in SPDR S&P Biotech ETF by 2.5% in the 3rd quarter, according to the company in its most recent filing with the SEC.



from Biotech News
Share:

Biogen (BIIB) Given a $427.00 Price Target by Mizuho Analysts

Biogen (BIIB) Given a $427.00 Price Target by Mizuho Analysts


The brokerage currently has a buy rating on the biotechnology company's stock. A number of other analysts have also weighed in on the stock.



from Biotech News
Share:

Public libraries, YMCAs offered Narcan kits Source: Cox Media Group

Public libraries, YMCAs offered Narcan kits Source: Cox Media Group


Public libraries and YMCAs across the United States soon will be equipped with a a nasal spray that works to counteract the effects of opioid overdoses, Time reported. Emergent BioSolutions, which this month completed its acquisition of Narcan maker Adapt Pharma, will provide a free kit that includes educational materials and two doses of the naxalone nasal spray,.



from Biotech News
Share:

Battles begin to turn in long war on TB

Battles begin to turn in long war on TB


Tuberculosis, a curable and preventable lung infection, killed more than 1.6 million people last year -- almost as many as HIV/AIDS and malaria combined -- and is the world's deadliest infectious disease. Tuberculosis, a curable and preventable lung infection, killed more than 1.6 million people last year -- almost as many as HIV/AIDS and malaria combined -- and is the world's deadliest infectious disease.



from Biotech News
Share:

La Jolla High principal: SDPD arrests person suspected of making threats to campus

La Jolla High principal: SDPD arrests person suspected of making threats to campus


San Diego police on Friday arrested a person suspected of making threats toward La Jolla High School in a pair of notes that were found by students and made mention of two specific dates, including Halloween, school officials said. Chuck Podhorsky, principal of the high school on Nautilus Street, sent an email to parents Thursday informing them of the threats, which mentioned Oct. 31 and Dec. 10 as the dates the campus would apparently be targeted.



from Biotech News
Share:

Current Shareholders: Zamansky LLC Investigates AmerisourceBergen (Abc) for Potential Breaches of Fiduciary Duties

Current Shareholders: Zamansky LLC Investigates AmerisourceBergen (Abc) for Potential Breaches of Fiduciary Duties


Oct 26, 2018--Zamansky LLC announces that it is investigating AmerisourceBergen Corporation for potential breaches of fiduciary duties by its senior officers and board of directors. If you are a shareholder of AmerisourceBergen who still holds your shares, please contact our firm for information.



from Biotech News
Share:

UPDATE 1-Gilead hepatitis C drug sales fall, but profit beats estimates

UPDATE 1-Gilead hepatitis C drug sales fall, but profit beats estimates


Third quarter sales of Gilead Sciences Inc's flagship hepatitis C drugs fell by more than half as competition increased, sending net profit down 22 percent from a year earlier, the U.S. biotechnology company reported on Thursday. But the results beat analyst estimates and Gilead slightly raised its full-year outlook for product sales to between $20.8 billion and $21.3 billion from a previous range of $20 billion to $21 billion.



from Biotech News
Share:

First Child Flu Death Of Season Reported In New York

First Child Flu Death Of Season Reported In New York


Health department officials in New York would not release the name, gender or specific age of the child, only saying the child was under 18 and resided in New York City. Nationally, flu activity has been minimal across the United States so far, according to the Centers for Disease Control and Prevention.



from Biotech News
Share:

Police remove dozens of demonstrators in janitors' protest

Police remove dozens of demonstrators in janitors' protest


Police removed dozens of demonstrators from a street near Eli Lilly's corporate headquarters in Indianapolis for blocking traffic during a protest seeking a better contract for janitors. Nearly 50 demonstrators with Service Employees International Union Local 1, including two city-county councilors, were issued written summons Thursday for violating a city ordinance and not complying with police.



from Biotech News
Share:

Boston Scientific Keeps Us Guessing on Recent Legal Victory

Boston Scientific Keeps Us Guessing on Recent Legal Victory


Boston Scientific won the right to stop Edwards Lifesciences from selling its Sapien 3 Ultra valve in Germany, but whether or not the company will exercise that right is unclear. Earlier this week, a German court sided with Boston Scientific in a patent case involving its transcatheter aortic valve replacement technology.



from Biotech News
Share:

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers


The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics. Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including financial strength, easy adaptation to change, and a research-driven environment.



from Biotech News
Share:

Finanzen: Private Haftpflichtversicherung : Private Haftpflichtversicherung

Wenn durch Sie jemand anderes zu Schaden kommt, haften Sie unbegrenzt. Eine Privat-Haftpflichtversicherung schützt Sie dann vor dem finanziellen Ruin.

from Finanztip Feed
Supported by Video Collection
Share:

FDA declines to approve pre-filled syringe version of Regeneron's Eylea

FDA declines to approve pre-filled syringe version of Regeneron's Eylea


REUTERS: Regeneron Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration declined to approve a pre-filled syringe version of its blockbuster eye drug Eylea, and has sought additional information regarding its manufacturing and supply processes. The drugmaker said the rejection does not affect its earlier expectation of launching the product in 2019.



from Biotech News
Share:

The ASX ends the week down almost 5pc

The ASX ends the week down almost 5pc


The local sharemarket has closed the week lower after a global sell-off pushed Australian shares to their lowest level in 12 months. The S&P/ASX 200 index fell 274.3 points, or 4.6 per cent, to 5665.2 this week, as local shares entered a technical correction on Thursday.



from Biotech News
Share:

Wie Antikörper gegen Malaria zusammen wirken

Wie Antikörper gegen Malaria zusammen wirken


image description
Wissenschaftler, die untersuchen, wie das menschliche Immunsystem sich gegen Malaria verteidigt, haben ein seltenes Phänomen entdeckt: Antikörper, die zusammenarbeiten, um sich an eine verwundbare Stelle auf dem Parasiten zu binden.Die neue Forschung zeigt, dass zusammenwirkende Antikörper dazu führ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Merck posts global sales of $11B in third quarter

Merck posts global sales of $11B in third quarter


This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Thursday, Oct. 25. FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co.



from Biotech News
Share:

Hirnfressende Amöben werden durch Silber-Nanopartikel gestoppt

Hirnfressende Amöben werden durch Silber-Nanopartikel gestoppt


Halloween ist direkt vor der Tür, und einige Leute werden feiern, indem sie sich gruselige Filme über hirnfressende Zombies ansehen. Aber noch beängstigender sind reale Parasiten, die sich vom menschlichen Gehirn ernähren, und sie können schwerer zu töten sein als ihre Horrorfilmpartner. Jetzt haben...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bilder von Antikörpern, die gegen Malaria zusammenwirken

Bilder von Antikörpern, die gegen Malaria zusammenwirken


image description
Wissenschaftler, die untersuchen, wie das menschliche Immunsystem sich gegen Malaria verteidigt, haben ein seltenes Phänomen entdeckt: Antikörper, die zusammenarbeiten, um sich an eine verwundbare Stelle auf dem Parasiten zu binden.Die neue Forschung zeigt, dass zusammenwirkende Antikörper dazu führ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Head to Head Analysis: Oncolytics Biotech (ONCYF) vs. The Competition

Head to Head Analysis: Oncolytics Biotech (ONCYF) vs. The Competition


Oncolytics Biotech is one of 524 public companies in the "Pharmaceutical preparations" industry, but how does it compare to its competitors? We will compare Oncolytics Biotech to related companies based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership. As a group, "Pharmaceutical preparations" companies have a potential upside of 67.71%.



from Biotech News
Share:

Single-dose flu pill wins FDA approval ahead of winter season

Single-dose flu pill wins FDA approval ahead of winter season


Xofluza, a pill for shortening the duration and easing symptoms of the flu. won Food and Drug Administration approval on Oct. 24, 2018.



from Biotech News
Share:

Kentucky attorney general to announce 8th opioid lawsuit

Kentucky attorney general to announce 8th opioid lawsuit


Beshear's office says he will announce the lawsuit Thursday afternoon against a pharmaceutical company contributing to the state's opioid problem. Beshear has already sued distributors AmerisourceBergen, Cardinal Health and McKesson Corp. He has also filed lawsuits against pharmaceutical manufacturers Johnson and Johnson, Walgreens, Mallinckrodt and Endo Pharmaceuticals.



from Biotech News
Share:

Finanzen: Übersicht Kreditkarte : Kreditkarte

Von gebührenfrei bis prepaid – wir haben die tatsächlichen Kosten von Kreditkarten geprüft. So finden Sie ein Angebot, das wirklich zu Ihnen passt.

from Finanztip Feed
Supported by Video Collection
Share:

US approves first new type of flu drug in 2 decades

US approves first new type of flu drug in 2 decades


Wednesday's approval of Xofluza for people age 12 and older comes ahead of the brunt of this winter's flu season. Xofluza is a pill that can reduce flu symptoms after one just dose.



from Biotech News
Share:

Finanzen: Bankenvergleich : Bankenvergleich

Mit dem Bankenvergleich von Finanztip finden Sie eine Bank, die Girokonto, Kreditkarte und Wertpapierdepot mit guten Konditionen anbietet.

from Finanztip Feed
Supported by Video Collection
Share:

Narcan to be offered to every public library and YMCA for free

Narcan to be offered to every public library and YMCA for free


The company behind the overdose-reversing drug Narcan plans to make free doses of its product available to every public library and YMCA across the country. Emergent BioSolutions made the announcement Wednesday afternoon as President Trump signed a bipartisan measure to confront the opioid crisis - now the deadliest drug overdose epidemic in U.S. history.



from Biotech News
Share:

Monsanto weed killer ruling is 1st step in long legal battle

Monsanto weed killer ruling is 1st step in long legal battle


In this June 28, 2011, file photo, bottles of Roundup herbicide, a product of Monsanto, are displayed on a store shelf in St. Louis. German drug and chemicals company Bayer AG announced Monday, May 23, 2016, that it has made a $62 billion offer to buy U.S.-based crops and seeds specialist Monsanto.



from Biotech News
Share:

"Pilze" und "Bürsten" helfen, krebsbekämpfende Nanopartikel im Körper zu überleben

"Pilze" und "Bürsten" helfen, krebsbekämpfende Nanopartikel im Körper zu überleben


image description
Bei einer Reihe von innovativen und lebensrettenden medizinischen Behandlungen, von Organersatz und Hauttransplantationen bis hin zur Krebstherapie und Chirurgie, hängt der Erfolg oft davon ab, dass man vorbeikommt oder das Immunsystem des Körpers abwehrt. In einer neuen Entwicklung, die auf die Unt...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Amgen slashes price of $14,000-a-year cholesterol drug

Amgen slashes price of $14,000-a-year cholesterol drug


The maker of an expensive cholesterol drug is slashing the list price, which should make it more affordable for patients. Amgen Inc. said Wednesday it is immediately cutting the price of Repatha by 60 percent, from about $14,000 to $5,850 per year.



from Biotech News
Share:

This 1981 electron microscope image made available by the Centers for ...

This 1981 electron microscope image made available by the Centers for ...


This 1981 electron microscope image made available by the Centers for Disease Control and Prevention shows a group of adenovirus virions. The adenovirus 7 strain, a common virus blamed for a deadly outbreak at a New Jersey children's rehabilitation center in October 2018, usually poses little risk for healthy people but can lead to dangerous pneumonia in already frail patients.



from Biotech News
Share:

Forward Pharma loses appeal in Tecfidera patent dispute with Biogen

Forward Pharma loses appeal in Tecfidera patent dispute with Biogen


REUTERS: A U.S. appeals court on Wednesday upheld a ruling that patents owned by Biogen Inc covering its blockbuster multiple sclerosis drug Tecfidera are valid, rejecting a challenge by Danish drugmaker Forward Pharma A/S.



from Biotech News
Share:

US advisory group urges hepatitis A shots for homeless

US advisory group urges hepatitis A shots for homeless


For the first time, a U.S. advisory committee is recommending a routine vaccination for homeless people, voting Wednesday to urge hepatitis A shots to prevent future outbreaks of the contagious liver disease. The Advisory Committee on Immunization Practices made the recommendation at a meeting in Atlanta.



from Biotech News
Share:

Sen. Joe Manchin Blasts Attorney General Patrick Morrisey Over Potential Opioid Settlement

Sen. Joe Manchin Blasts Attorney General Patrick Morrisey Over Potential Opioid Settlement


Surrounded by first responders and caregivers, U.S. Sen. Joe Manchin, D-W.Va., raised alarm bells about a potential settlement between West Virginia Attorney General Patrick Morrisey - his Republican opponent for re-election - and a major distributor of opioid pills. According to sources Manchin would not identify, the senator said Tuesday the state is getting ready to settle a lawsuit with McKesson Corp., a pharmaceutical distribution company that has shipped millions of painkiller doses to West Virginia over the past 12 years.



from Biotech News
Share:

USANA Health Sciences (USNA) Issues Quarterly Earnings Results

USANA Health Sciences (USNA) Issues Quarterly Earnings Results


USANA Health Sciences posted its quarterly earnings data on Tuesday. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.14, RTT News reports.



from Biotech News
Share:

Finanzen: Ratgeber kostenlose Kreditkarte : Kostenlose Kreditkarte

Vermeintlich kostenlose Kreditkarten können durchaus etwas kosten: Hohe Gebühren machen sie manchmal richtig teuer. So finden Sie gute und preiswerte Anbieter.

from Finanztip Feed
Supported by Video Collection
Share:

Bain, Pfizer launch biotech startup to tackle brain disorders

Bain, Pfizer launch biotech startup to tackle brain disorders


Bain Capital LP and Pfizer Inc. have teamed up to launch a new biotech in the Boston area focused on neurological disorders, including Parkinson's and Alzheimer's disease. The new company, called Cerevel Therapeutics LLC, is starting out with a $350 million investment from funds affiliated with Bain.



from Biotech News
Share:

Whittier Trust Co. Raises Position in SPDR S&P Biotech Etf

Whittier Trust Co. Raises Position in SPDR S&P Biotech Etf


Whittier Trust Co. increased its stake in shares of SPDR S&P Biotech ETF by 1.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.



from Biotech News
Share:

Finanzen: Schutzbrief : Kfz-Schutzbrief

Ein Schutzbrief fürs Auto bietet Pannenhilfe im In- und Ausland. Damit sind Kfz-Schutzbriefe eine echte Alternative zu Automobilklubs.

from Finanztip Feed
Supported by Video Collection
Share:

U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z

U.S. giant Johnson & Johnson makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z


U.S. health care conglomerate Johnson & Johnson said on Tuesday it will buy all outstanding shares of Japanese skin care firm Ci:z Holdings Co. that it does not already own for A 230 billion in cash.



from Biotech News
Share:

Finanzen: Billiger telefonieren ins Ausland : Billig telefonieren ins Ausland

Wer mit Freunden oder Familie im Ausland telefoniert, zahlt oft einen hohen Preis. Wir stellen günstige Alternativen vor.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Gebrauchtwagenkauf - Mängelhaftung : Gewährleistung beim Gebrauchtwagenkauf

Wer einen Gebrauchtwagen kauft, sollte dessen Zustand genau prüfen und seine Rechte als Kunde kennen. Kaufen Sie bei einem Händler und nicht von privat, so können Sie Mängel am Wagen einfacher reklamieren.

from Finanztip Feed
Supported by Video Collection
Share:

FundX Investment Group LLC Purchases 3,787 Shares of SPDR S&P Biotech Etf

FundX Investment Group LLC Purchases 3,787 Shares of SPDR S&P Biotech Etf


FundX Investment Group LLC lifted its position in shares of SPDR S&P Biotech ETF by 19.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,150 shares of the exchange traded fund's stock after buying an additional 3,787 shares during the quarter.



from Biotech News
Share:

Amgen investiert 66 Millionen Dollar in Oxford Nanopore Technologies

Amgen investiert 66 Millionen Dollar in Oxford Nanopore Technologies


Amgen und Oxford Nanopore Technologies Ltd. gaben die Beteiligung von Amgen in Höhe von 50 Millionen Pfund (66 Millionen Dollar) an Oxford Nanopore bekannt, einem in Privatbesitz befindlichen, in Großbritannien ansässigen Unternehmen, das eine neue Generation von tragbaren, echtzeitfähigen genetisch...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Sartorius wächst weiter zweistellig

Sartorius wächst weiter zweistellig


Mit zweistelligen Zuwächsen bei Umsatz und Gewinn hat Sartorius seinen Wachstumskurs fortgesetzt. „Sartorius hat in den ersten neun Monaten 2018 ein sehr gutes organisches Wachstum erzielt“, sagte der Vorstandsvorsitzende Dr. Joachim Kreuzburg. „Das gilt insbesondere für die Bioprozess-Sparte, die ü...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Former La Jolla Teacher Pleads Not Guilty to Rape

Former La Jolla Teacher Pleads Not Guilty to Rape


Jonathan Sammartino faced charges of statutory rape and sex acts with a minor. NBC 7's Melissa Adan has more on the former La Jolla high school teacher.



from Biotech News
Share:

J&J offers $2 bln to buy Japan's Ci:z

J&J offers $2 bln to buy Japan's Ci:z


U.S. healthcare conglomerate Johnson & Johnson said it will buy all outstanding shares of Japanese skincare firm Ci:z Holdings that it does not already own for $2 billion in cash. Fred Katayama reports.



from Biotech News
Share:

Quest Diagnostics (DGX) Issues Earnings Results

Quest Diagnostics (DGX) Issues Earnings Results


Quest Diagnostics released its quarterly earnings data on Tuesday. The medical research company reported $1.68 earnings per share for the quarter, hitting the Zacks' consensus estimate of $1.68, MarketWatch Earnings reports.



from Biotech News
Share:

US judge affirms Monsanto weed-killer verdict, slashes damages

US judge affirms Monsanto weed-killer verdict, slashes damages


A U.S. judge on Monday affirmed a verdict against Bayer AG unit Monsanto that found its glyphosate-based weed-killers responsible for a man's terminal cancer, but said the US$250 million punitive damages portion of the award had to be reduced. Plaintiff Dewayne Johnson leaves the courtroom following a post-trial hearing at the Superior Court in San Francisco, California, U.S., October 10, 2018.



from Biotech News
Share:

Young Visits IU's Melvin and Bren Simon Cancer Center, Tours Breast Cancer Research Laboratory

Young Visits IU's Melvin and Bren Simon Cancer Center, Tours Breast Cancer Research Laboratory


Saturday, coinciding with Breast Cancer Awareness Month, U.S. Senator Todd Young visited Indiana University's Melvin and Bren Simon Cancer Center and toured one of their breast cancer research laboratories. Senator Young met with IU Simon Cancer Center Director Dr. Patrick J. Loehrer Sr. and other IU School of Medicine and Simon Cancer Center researchers to learn more about the importance of National Institutes of Health research investments, and their positive health and economic outcomes.



from Biotech News
Share:

Finanzen: Billiger telefonieren ins Ausland : Billig telefonieren ins Ausland

Wer mit Freunden oder Familie im Ausland telefoniert, zahlt oft einen hohen Preis. Wir stellen günstige Alternativen vor.

from Finanztip Feed
Supported by Video Collection
Share:

Researchers wake-up DNA from soil bacteria to discover novel acid antibiotic

Researchers wake-up DNA from soil bacteria to discover novel acid antibiotic


Scleric Acid has been discovered by capturing and engineering a DNA fragment from soil bacteria Streptomyces sclerotialus, and could help fight bacterial infections. Scleric Acid has been discovered by capturing and engineering a DNA fragment from soil bacteria Streptomyces sclerotialus, and could help fight bacterial infections -- by researchers at the School of Life Sciences and Department of Chemistry, University of Warwick.



from Biotech News
Share:

Banks, energy lead ASX to third straight loss

Banks, energy lead ASX to third straight loss


The S&P/ASX 200 Index dropped 61.8 points, or 1.1 per cent, to 5843.1, as the index heavyweights across the board were weighed by poor investor sentiment. "Growing uncertainty in all corners of the globe has brought renewed uncertainty to the markets," said City Index research analyst Gary Burton.



from Biotech News
Share:

155 cases of polio-like illness now under investigation, CDC says

155 cases of polio-like illness now under investigation, CDC says


The US Centers for Disease Control and Prevention reported Monday that there are 155 patients under investigation this year for acute flaccid myelitis, a condition that that can cause paralysis and mostly affects children. The US Centers for Disease Control and Prevention reported Monday that there are 155 patients under investigation this year for acute flaccid myelitis, a condition that that can cause paralysis and mostly affects children.



from Biotech News
Share:

Pathogene können sich der Immunantwort mit metallfreiem Enzym entziehen

Pathogene können sich der Immunantwort mit metallfreiem Enzym entziehen


image description
Einige bakterielle Krankheitserreger, einschließlich solcher, die Streptokokken und Lungenentzündungen verursachen, sind in der Lage, die notwendigen Bausteine zu schaffen, um ihre DNA ohne die normalerweise benötigten Metallionen zu replizieren. Dieser Prozess kann es ermöglichen, dass sich infekti...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Steudle will lead the company's Transportation Systems Group, and its subsidiary CAVita.



from Biotech News
Share:

Oncolytics Biotech Announces Positive Clinical Trial Results for...

Oncolytics Biotech Announces Positive Clinical Trial Results for...


Oncolytics Biotech Inc. , currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold tumors hot, today announced positive clinical trial results for pelareorep in the treatment of patients with KRAS mutant metastatic colorectal cancer. Patients receiving treatment with the recommended phase 2 dose of pelareorep in combination with FOLFIRI/B had progression free survival of 65.6 weeks and an overall survival of 107.5 weeks, which exceeded expectations when compared to historical data.



from Biotech News
Share:

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab)...

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab)...


Oct 22, 2018-- Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo and Yervoy , versus Yervoy alone, in patients with advanced melanoma. With a minimum follow-up of 48 months, four-year overall survival rates were 53% for the Opdivo plus Yervoy combination, 46% for Opdivo alone, and 30% for Yervoy alone.



from Biotech News
Share:

The long-shot treatment that's expanding Maine's frontier of cancer care

The long-shot treatment that's expanding Maine's frontier of cancer care


The Westbrook man had already undergone the standard treatments following his diagnosis in March 2016: surgery, radiation, chemotherapy and even immunotherapy, a newer generation of treatment that boosts the immune system's ability to fight cancer cells. As with any other patient with that form of the disease, the dangerous cells metastasizing in his body had originated in his colon.



from Biotech News
Share:

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer


Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE in combination with fulvestrant compared to placebo plus fulvestrant in women with hormone receptor-positive , human epidermal growth factor receptor 2-negative metastatic breast cancer whose disease progressed on or after prior endocrine therapy. In the study, there was a numerical improvement in OS of nearly seven months with IBRANCE plus fulvestrant compared to placebo plus fulvestrant, although this difference did not reach the prespecified threshold for statistical significance .



from Biotech News
Share:

-$0.06 Earnings Per Share Expected for Alkermes Plc (ALKS) This Quarter

-$0.06 Earnings Per Share Expected for Alkermes Plc (ALKS) This Quarter


Equities analysts expect that Alkermes Plc will report earnings per share of for the current quarter, Zacks reports. Four analysts have made estimates for Alkermes' earnings.



from Biotech News
Share:

Comparing Luminex

Comparing Luminex


Luminex and Lombard Medical are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends. 82.2% of Luminex shares are owned by institutional investors.



from Biotech News
Share:

Merck KGaA (MRK) Given a 100.00 Price Target by Commerzbank Analysts

Merck KGaA (MRK) Given a 100.00 Price Target by Commerzbank Analysts


Several other analysts also recently issued reports on the stock. JPMorgan Chase & Co.



from Biotech News
Share:

CSL, banks weigh as ASX falls for second session

CSL, banks weigh as ASX falls for second session


"Market sentiments could face a bigger challenge this week," said CMC Markets market analyst Jonathen Chan. "The US 10-year bond yield is edging closer to 3.2 per cent [and] investor buying could be limited by a higher borrowing cost and less stimulative news."



from Biotech News
Share:

Nanokäfige im Labor und im Computer

Nanokäfige im Labor und im Computer


image description
Nanokäfige sind hochinteressante molekulare Strukturen mit Hohlräumen, die z.B. in der Medizin als Träger kleinerer Moleküle genutzt werden können. Kurze Abschnitte des DNA-Moleküls sind perfekte Kandidaten für das kontrollierbare Design neuartiger Nanokäfige, der DNA-basierten Dendrimere. Wie man d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Loxo Oncology Announces Larotrectinib Clinical Update in Patients...

Loxo Oncology Announces Larotrectinib Clinical Update in Patients...


Loxo Oncology, Inc. , a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, and Bayer AG, Germany, today announced updated clinical data for larotrectinib, an investigational oral, selective, and CNS-active TRK inhibitor, in adult and pediatric patients with TRK fusion cancers. The update included approximately one year of additional follow-up for the 55 patients described in the larotrectinib New England Journal of Medicine publication from February 2018.



from Biotech News
Share:

Johnson & Johnson (JNJ) Stake Lessened by Wetherby Asset Management Inc.

Johnson & Johnson (JNJ) Stake Lessened by Wetherby Asset Management Inc.


Wetherby Asset Management Inc. cut its holdings in Johnson & Johnson by 4.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,412 shares of the company's stock after selling 2,459 shares during the period.



from Biotech News
Share:

Johnson & Johnson (JNJ) Stake Lowered by Douglass Winthrop Advisors LLC

Johnson & Johnson (JNJ) Stake Lowered by Douglass Winthrop Advisors LLC


Douglass Winthrop Advisors LLC reduced its position in shares of Johnson & Johnson by 1.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 209,201 shares of the company's stock after selling 2,081 shares during the period.



from Biotech News
Share:

Zacks: Brokerages Anticipate Quest Diagnostics Inc (DGX) Will...

Zacks: Brokerages Anticipate Quest Diagnostics Inc (DGX) Will...


Brokerages predict that Quest Diagnostics Inc will post $1.95 billion in sales for the current quarter, Zacks reports. Eight analysts have issued estimates for Quest Diagnostics' earnings.



from Biotech News
Share:

Analysts Anticipate IDEXX Laboratories, Inc. (IDXX) to Post $0.98 EPS

Analysts Anticipate IDEXX Laboratories, Inc. (IDXX) to Post $0.98 EPS


Equities analysts expect that IDEXX Laboratories, Inc. will announce earnings per share of $0.98 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for IDEXX Laboratories' earnings, with the highest EPS estimate coming in at $0.99 and the lowest estimate coming in at $0.96.



from Biotech News
Share:

Illumina, Inc. (ILMN) Expected to Post Quarterly Sales of $825.07 Million

Illumina, Inc. (ILMN) Expected to Post Quarterly Sales of $825.07 Million


Equities research analysts expect Illumina, Inc. to report sales of $825.07 million for the current fiscal quarter, according to Zacks . Six analysts have provided estimates for Illumina's earnings, with the highest sales estimate coming in at $838.99 million and the lowest estimate coming in at $775.00 million.



from Biotech News
Share:

Biogen (BIIB) Downgraded to Hold at BidaskClub

Biogen (BIIB) Downgraded to Hold at BidaskClub


BIIB has been the subject of a number of other reports. Citigroup dropped their price objective on shares of Biogen from $483.00 to $470.00 and set a buy rating for the company in a report on Monday, October 8th.



from Biotech News
Share:

Immunotherapy scores a first win against some breast cancers

Immunotherapy scores a first win against some breast cancers


This undated fluorescence-colored microscope image made available by the National Institutes of Health in September 2016 shows a culture of human breast cancer cells.



from Biotech News
Share:

Last flu season was deadly. Did you get a shot to protect yourself for this one?

Last flu season was deadly. Did you get a shot to protect yourself for this one?


Months out from the nation's deadliest flu season in decades, public health officials are urging people to get their flu shot, including in Whatcom County where the flu already is making people ill. About 80,000 people in the U.S. died from the illness and its complications last flu season, Dr. Robert Redfield, director of the Centers for Disease Control and Prevention, told the Associated Press in September.



from Biotech News
Share:

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Shows Promising Results in Patients with Advanced Form of Bladder Cancer

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Shows Promising Results in Patients with Advanced Form of Bladder Cancer


Oct 20, 2018-- Bristol-Myers Squibb Company today announced follow-up data evaluating Opdivo monotherapy and Opdivo in combination with Yervoy in patients with platinum-pretreated metastatic urothelial carcinoma . Results from the Phase 1/2 CheckMate -032 trial showed that patients who received the combination of Opdivo 1 mg/kg plus Yervoy 3 mg/kg experienced a higher objective response rate compared to those who received Opdivo 3 mg/kg plus Yervoy 1 mg/kg or Opdivo alone.



from Biotech News
Share:

Contrasting Impax Laboratories

Contrasting Impax Laboratories


Impax Laboratories and Corbus Pharmaceuticals are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings. Corbus Pharmaceuticals has lower revenue, but higher earnings than Impax Laboratories.



from Biotech News
Share:

Zacks: Analysts Anticipate Quest Diagnostics Inc (DGX) to Post $1.68 EPS

Zacks: Analysts Anticipate Quest Diagnostics Inc (DGX) to Post $1.68 EPS


Equities analysts expect that Quest Diagnostics Inc will announce earnings per share of $1.68 for the current quarter, Zacks reports. Eight analysts have issued estimates for Quest Diagnostics' earnings, with the lowest EPS estimate coming in at $1.65 and the highest estimate coming in at $1.74.



from Biotech News
Share:

Australian watchdog's appeal against Pfizer ruling dismissed by court

Australian watchdog's appeal against Pfizer ruling dismissed by court


Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor. FILE PHOTO: A man walks past Pfizer's world headquarters in New York April 28, 2014.



from Biotech News
Share:

Shire's drug for rare swelling disorder wins European panel green light

Shire's drug for rare swelling disorder wins European panel green light


A European Medicines Agency panel on Friday recommended approving a potential blockbuster drug from Shire Plc to treat patients aged 12 and older with a rare hereditary disease that causes swelling in different parts of the body. FILE PHOTO: An aircract flies over The European Medecines Agency and Ernst and Young's building in Canary Wharf on a clear morning in London, Britain, August 8, 2018.



from Biotech News
Share:

Scientists are searching for answers to AFM, the illness causing polio-like paralysis in children

Scientists are searching for answers to AFM, the illness causing polio-like paralysis in children


The Centers for Disease Control and Prevention has counted 386 cases of acute flaccid myelitis since August 2014. The illness mainly strikes children.



from Biotech News
Share:

The Chicago Tylenol Murders of 1982

The Chicago Tylenol Murders of 1982


I don't know how many people under the age of 35 know about the Chicago Tylenol murders , but for a few weeks in 1982, it was a national news sensation. Seven people in the Chicago area died after ingesting Tylenol capsules laced with potassium cyanide.



from Biotech News
Share:

Acura Pharmaceuticals (ACUR) Upgraded to Buy by ValuEngine

Acura Pharmaceuticals (ACUR) Upgraded to Buy by ValuEngine


Shares of Acura Pharmaceuticals stock opened at $0.26 on Wednesday. The company has a quick ratio of 0.23, a current ratio of 0.23 and a debt-to-equity ratio of -0.54.



from Biotech News
Share:

Inogen Inc (INGN) Shares Sold by Peregrine Capital Management LLC

Inogen Inc (INGN) Shares Sold by Peregrine Capital Management LLC


Peregrine Capital Management LLC decreased its position in Inogen Inc by 32.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 133,197 shares of the medical technology company's stock after selling 63,064 shares during the period.



from Biotech News
Share:

Finanzen: Handytarife-Vergleich : Handytarife-Vergleich

Es gibt unzählige Handytarife. Unser Vergleichsrechner zeigt, welcher Tarif zu Ihnen passt.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: GKV-Ratgeber : Gesetzliche Krankenversicherung (GKV)

Ein Wechsel der gesetzlichen Kasse ist unproblematisch. So recherchieren Sie die Kassen mit den besten Zusatzleistungen für Ihre Bedürfnisse.

from Finanztip Feed
Supported by Video Collection
Share:

Shire PLC (SHP) Receives Consensus Recommendation of "Buy" from Analysts

Shire PLC (SHP) Receives Consensus Recommendation of "Buy" from Analysts


Shares of Shire PLC have earned a consensus rating of "Buy" from the twenty-two ratings firms that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company.



from Biotech News
Share:

Dr. Fabrizio Guidi übernimmt Vorsitz der Geschäftsführung von Sanofi in Deutschland

Dr. Fabrizio Guidi übernimmt Vorsitz der Geschäftsführung von Sanofi in Deutschland


image description
Der Ausichtrat der Sanofi-Aventis Deutschland GmbH hat Dr. Fabrizio Guidi mit Wirkung zum 1. Januar 2019 zum Vorsitzenden der Geschäftsführung ernannt. Er folgt in dieser Funktion Clemens Kaiser, der zu diesem Zeitpunkt nach Kanada zurückkehren und dort eine andere Aufgabe übernehmen wird. Der 49-jä...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Mystery illness confirmed in Iowa, suspected in Nebraska

Mystery illness confirmed in Iowa, suspected in Nebraska


Officials say a rare illness that can paralyze children has been confirmed in two Iowa cases and is suspected in one Nebraska case. The federal Centers for Disease Control and Prevention says at least 62 cases of acute flaccid myelitis have been confirmed in 22 states this year.



from Biotech News
Share:

Amgen, Inc. (AMGN) Stake Increased by Verity & Verity LLC

Amgen, Inc. (AMGN) Stake Increased by Verity & Verity LLC


Verity & Verity LLC increased its stake in shares of Amgen, Inc. by 3.8% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 18,787 shares of the medical research company's stock after purchasing an additional 683 shares during the period.



from Biotech News
Share:

Ein menschliches Gehirnmodell in einer Petrischale?

Ein menschliches Gehirnmodell in einer Petrischale?


Forscher auf der ganzen Welt sind nun in der Lage, die strukturellen, zellulären und entwicklungsbezogenen Feinheiten des menschlichen Gehirns mit Hilfe von biotechnologisch hergestellten Stammzell-basierten Modellen, den Organoiden, zu untersuchen. Aber die Ethik, die Forscher und Regulierungsbehör...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Takeda gets Japanese approval for US$62 billion Shire purchase

Takeda gets Japanese approval for US$62 billion Shire purchase


Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its US$62 billion acquisition of Shire Plc , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018.



from Biotech News
Share:

Drug-resistant salmonella from chicken sickens nearly 100

Drug-resistant salmonella from chicken sickens nearly 100


At least 92 people in 29 states have been infected with a strain of multidrug-resistant salmonella after coming into contact with a variety of raw chicken products, the US Centers for Disease Control and Prevention said Wednesday. At least 92 people in 29 states have been infected with a strain of multidrug-resistant salmonella after coming into contact with a variety of raw chicken products, the US Centers for Disease Control and Prevention said Wednesday.



from Biotech News
Share:

Finanzen: Flugstornierung : Flugstornierung: Gebühren und Steuern

Flug verpasst oder storniert? Dann haben Sie Anspruch auf Erstattung von Steuern und Gebühren – eventuell sogar auf den gesamten Ticketpreis.

from Finanztip Feed
Supported by Video Collection
Share:

Poverty tied to worse heart health among US teens

Poverty tied to worse heart health among US teens


Adolescents from low-income families are more likely than their affluent peers to have risk factors for cardiovascular disease like obesity, inactivity, poor nutrition and tobacco use, a U.S. study suggests. Income inequality has long been linked to disparities in heart disease risk among adults.



from Biotech News
Share:

Finanzen: Entschädigung bei Flugausfall : Fluggastrechte – Flugannullierung

Mit unserem Onlinerechner finden Sie ganz einfach heraus, wie viel Geld Ihnen zusteht, wenn Ihr Flug gestrichen wurde.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Mieterhöhung : Mieterhöhung

Wie oft und wie hoch – für Mieterhöhungen gelten klare Vorgaben. Hier finden Sie die wichtigsten Tipps für Mieter und Vermieter.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Fluggastrechte : Fluggastrechte

Als Passagier in der EU haben Sie Anspruch auf Verpflegung und eine Entschädigung, wenn Ihr Flug stark verspätet ist. Lesen Sie hier, was Ihnen zusteht.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Gebrauchtwagenkauf - Mängelhaftung : Gewährleistung beim Gebrauchtwagenkauf

Wer einen Gebrauchtwagen kauft, sollte dessen Zustand genau prüfen und seine Rechte als Kunde kennen. Kaufen Sie bei einem Händler und nicht von privat, so können Sie Mängel am Wagen einfacher reklamieren.

from Finanztip Feed
Supported by Video Collection
Share:

Pfizer to Cut Around 2% of Jobs Through Early Next Year

Pfizer to Cut Around 2% of Jobs Through Early Next Year


U.S. drugmaker Pfizer Inc. plans to reduce its global headcount by around 2 percent through voluntary retirements and layoffs this year and early next year. The move follows the announcement earlier this month that Chief Operating Officer Albert Bourla would succeed Ian Read as chief executive in January.



from Biotech News
Share:

Finanzen: Kaufrecht : Umtauschrecht beim Onlinekauf und Versandhandel

Viele Versandhändler werben gerne mit Schnäppchen. Gefällt die Ware nicht, können Sie innerhalb von zwei Wochen widerrufen.

from Finanztip Feed
Supported by Video Collection
Share:

Merck nimmt neues Verpackungszentrum für Pharma-Produkte in Darmstadt in Betrieb

Merck nimmt neues Verpackungszentrum für Pharma-Produkte in Darmstadt in Betrieb


image description
Merck hat an seiner Konzernzentrale in Darmstadt ein neues Verpackungszentrum in Betrieb genommen. An der Eröffnungsfeier nahmen neben Stefan Oschmann, Vorsitzender der Geschäftsleitung von Merck, auch Stefan Grütter, Minister für Soziales und Integration des Landes Hessen sowie Jochen Partsch, Ober...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis hebt Umsatzausblick und übernimmt US-Firma Endocyte

Novartis hebt Umsatzausblick und übernimmt US-Firma Endocyte


(dpa-AFX) Novartis wird nach einem Umsatzanstieg im dritten Quartal für das Gesamtjahr etwas optimistischer. Das Unternehmen traut sich nun einen Umsatzzuwachs im mittleren einstelligen Prozentbereich zu, nachdem zuvor noch ein Plus im niedrigen bis mittleren einstelligen Bereich angepeilt worden wa...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

FDA approves Pfizer's drug for advanced breast cancer

FDA approves Pfizer's drug for advanced breast cancer


The U.S. Food and Drug Administration said on Tuesday it approved Pfizer Inc's drug for an advanced form of breast cancer tied to an inherited gene mutation. The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018.



from Biotech News
Share:

Maschinelles Lernen deckt neue zelluläre Akteure in der Tumormikroumgebung auf

Maschinelles Lernen deckt neue zelluläre Akteure in der Tumormikroumgebung auf


image description
Neue Erkenntnisse von CytoReason zeigen mögliche neue zelluläre Akteure im Tumormikroumfeld, die den Behandlungsprozess für die am dringendsten bedürftigen Patienten beeinflussen könnten - diejenigen, die bereits nicht auf die Immuntherapie mit Ipilimumab (Anti-CTLA4) angesprochen haben. Nach der Va...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Evotec und Ferring gehen strategische Allianz ein

Evotec und Ferring gehen strategische Allianz ein


Evotec AG und Ferring Pharmaceuticals gaben den Beginn einer strategischen Allianz zur Erforschung und Entwicklung niedermolekularer Therapien zur Behandlung von Patienten mit Fertilitätsproblemen und gynäkologischen Erkrankungen bekannt. Evotec setzt ihre Wirkstoffforschungsplattform ein, um neuart...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Polio-like disease AFM now confirmed in 22 states, CDC says

Polio-like disease AFM now confirmed in 22 states, CDC says


The paralyzing, polio-like disease acute flaccid myelitis or AFM, is now reported in 22 states across the U.S., according to the Centers for Disease Control and Prevention. Nancy Messonnier, Director of the National Center for Immunization and Respiratory Diseases, said the CDC is investigating 127 case with 62 confirmed, and it seems to be hitting children more than other age groups.



from Biotech News
Share:

UPDATE 2-Johnson & Johnson edges past profit estimates, lifts outlook

UPDATE 2-Johnson & Johnson edges past profit estimates, lifts outlook


Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its cancer drugs Zytiga and Imbruvica helped offset falling sales of arthritis treatment Remicade. Shares were unchanged in premarket trading, with the company forecasting adjusted 2018 earnings per share in the range of $8.13 and $8.18, marginally up from a previous range of $8.07 to $8.17.



from Biotech News
Share:

San Diego will pay $1.4M for La Jolla Shores flood damage blamed on aging storm drain system

San Diego will pay $1.4M for La Jolla Shores flood damage blamed on aging storm drain system


San Diego is paying $1.4 million to cover flood damage in early 2016 to a single-family home in La Jolla Shores, damage that is being blamed on a clogged city storm drain. The payout is one of many by San Diego related to its aging storm drain system, which the city's independent budget analyst has urged city officials to upgrade to reduce liability from property damage and potential sinkholes.



from Biotech News
Share:

Investors Sell Shares of SPDR S&P Biotech Etf

Investors Sell Shares of SPDR S&P Biotech Etf


Traders sold shares of SPDR S&P Biotech ETF on strength during trading on Tuesday. $86.52 million flowed into the stock on the tick-up and $117.81 million flowed out of the stock on the tick-down, for a money net flow of $31.29 million out of the stock.



from Biotech News
Share:

Finanzen: Handyvertrag : Handyverträge

Zum Handyvertrag gibt es meist gleich ein neues Smartphone dazu. Wir haben untersucht, ob es nicht günstiger ist, das Gerät selbst zu kaufen.

from Finanztip Feed
Supported by Video Collection
Share:

Neue Medikamente treiben Roche an

Neue Medikamente treiben Roche an


(dpa-AFX) Der Schweizer Pharmakonzern Roche sieht sich nach einem Umsatzplus in den ersten neuen Monaten auf gutem Weg zu seinen Jahreszielen. Wie schon in den Vorquartalen habe auch im dritten Jahresviertel die starke Nachfrage nach neuen Medikamenten weiter angehalten, betonte Konzernchef Severin ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bei Johnson & Johnson brummt das Pharmageschäft

Bei Johnson & Johnson brummt das Pharmageschäft


(dpa-AFX) Der US-Gesundheitskonzern Johnson & Johnson (J&J) konnte im dritten Quartal dank seines Pharmageschäfts bei Umsatz und Gewinn weiter zulegen. Dabei schnitt der Hersteller von Pflegeprodukten, Medizintechnik und Arzneimitteln besser ab als von Analysten erwartet. J&J erhöhte zudem seine Pro...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

AstraZeneca kommt mit Krebsmittel Lynparza in den USA voran

AstraZeneca kommt mit Krebsmittel Lynparza in den USA voran


(dpa-AFX) Der britisch-schwedische Pharmakonzern AstraZeneca und sein Forschungspartner Merck & Co haben einen weiteren Erfolg für den Hoffnungsträger Lynparza erzielt. Die US-Medikamentenaufsicht FDA erteilte dem Medikament für die Behandlung von Bauchspeicheldrüsenkrebs den sogenannten "Orphan Dru...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

A nurse prepares a flu shot Feb. 7, 2018, at the Salvation Army in Atlanta.

A nurse prepares a flu shot Feb. 7, 2018, at the Salvation Army in Atlanta.


The unidentified child tested positive for the influenza B virus and died between Sept. 30 and Oct. 6, according to Florida Department of Health's Bureau of Epidemiology.



from Biotech News
Share:

Moleculin Biotech (MBRX) PT Set at $8.00 by Roth Capital

Moleculin Biotech (MBRX) PT Set at $8.00 by Roth Capital


The firm currently has a "buy" rating on the stock. Roth Capital's price target suggests a potential upside of 488.24% from the stock's previous close.



from Biotech News
Share:

Der dichteste nicht-aminoglykosidische Ligand für die bakterielle ribosomale RNA A-Site

Der dichteste nicht-aminoglykosidische Ligand für die bakterielle ribosomale RNA A-Site


image description
Eine Forschungsgruppe der Tohoku University hat eine signifikante Entdeckung mit positiven Auswirkungen auf die Entwicklung von Medikamenten zur Bakterienbekämpfung gemacht. Die Aminoacyl-tRNA-Site (A-Site) der 16S-RNA-Dekodierungsregion im bakteriellen Ribosom verspricht eine neue Ära der Entwicklu...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Us Stocks-Strong blue-chip results power Wall St rally

Us Stocks-Strong blue-chip results power Wall St rally


The three main Wall Street indexes rose more than 1 percent on Tuesday as upbeat earnings from blue-chips such as Johnson & Johnson and Goldman Sachs eased jitters over the impact of rising interest rates and tariffs on corporate profits. Traders work on the floor of the New York Stock Exchange in New York, U.S., October 12, 2018.



from Biotech News
Share:

Prescription drugs, lower taxes, power J&J 3Q beat

Prescription drugs, lower taxes, power J&J 3Q beat


This Sept. 13, 2016, file photo, shows a selection of Johnson & Johnson brand first aid products arranged for a photo in Surfside, Fla.



from Biotech News
Share:

Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal

Chinese drug regulator fines Changsheng Bio-Tech unit over vaccine scandal


China's drug regulator imposed penalties on a unit of Changsheng Bio-Technology worth 9.1 billion yuan over a vaccine scandal, Xinhua news agency said on Tuesday. FILE PHOTO: A sign of vaccine maker Changsheng Bio-technology Co Ltd is pictured at its building in Changchun, Jilin, China July 23, 2018.



from Biotech News
Share:

Quest Diagnostics (DGX) to Release Quarterly Earnings on Tuesday

Quest Diagnostics (DGX) to Release Quarterly Earnings on Tuesday


Quest Diagnostics will be issuing its quarterly earnings data before the market opens on Tuesday, October 23rd. Analysts expect the company to announce earnings of $1.68 per share for the quarter.



from Biotech News
Share:

Finanzen: Schadenfreiheitsrabatt übertragen : Schadenfreiheitsrabatt übertragen

Ihr könnt die Schadensfreiheitsklasse auf einen Familienmitglied übertragen, so dass dieser sich viel Geld spart.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Strompreis : Strompreise

Strompreise können sich je nach Anbieter stark unterscheiden. Bei den Kosten pro Kilowattstunde kommt es aber auch darauf an, wo Sie wohnen.

from Finanztip Feed
Supported by Video Collection
Share:

Jurors urge San Francisco judge to not throw out $289M Roundup verdict

Jurors urge San Francisco judge to not throw out $289M Roundup verdict


Containers of Roundup, a weed killer made by Monsanto, on a shelf at a hardware store in Los Angeles in 2017. Jurors who found that agribusiness giant Monsanto's Roundup weed killer contributed to a school groundskeeper's cancer are urging a San Francisco judge not to throw out the bulk of their $289 million award in his favor, a newspaper reported today.



from Biotech News
Share:

MAE is MIA No Longer: Delaware Court Upholds Use of "Material...

MAE is MIA No Longer: Delaware Court Upholds Use of "Material...


In Akorn, Inc. v. Fresenius Kabi AG , the Delaware Chancery Court held that Fresenius, a German pharmaceutical company, was justified in invoking a "material adverse event" clause to terminate its $4.8 billion merger agreement with American generics manufacturer Akorn, Inc. Although MAE clauses are common in large transactions, Akorn marks the first time that the Chancery Court has upheld a buyer's use of such a clause to back out of a merger agreement.



from Biotech News
Share:

Merck zielt ab 2019 wieder auf profitables Wachstum

Merck zielt ab 2019 wieder auf profitables Wachstum


Merck erwartet ab dem kommenden Jahr starke Wachstumsimpulse, wie das Unternehmen Analysten und Investoren auf seinem Kapitalmarkttag mitgeteilt hat. „2018 war für Merck ein herausforderndes Jahr. Wir haben richtungsweisende Entscheidungen getroffen, die ab kommendem Jahr zu profitablem Wachstum füh...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

'To them it was a science fiction story': a VC who dropped out of Mit ...

'To them it was a science fiction story': a VC who dropped out of Mit ...


'To them it was a science fiction story': A VC who's been investing in anti-aging research for 7 years explains why investors are starting to pour hundreds of millions into a field they had previously snubbed When Laura Deming launched the Longevity Fund seven years ago, there weren't many investments going into experimental treatments aimed at helping us live healthier and longer. But now, the anti-aging field about to take off, she says.



from Biotech News
Share:

Havens Advisors LLC Purchases Shares of 11,000 Sodastream International Ltd

Havens Advisors LLC Purchases Shares of 11,000 Sodastream International Ltd


Havens Advisors LLC purchased a new stake in Sodastream International Ltd during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 11,000 shares of the company's stock, valued at approximately $1,574,000.



from Biotech News
Share:

Chinese Drugmaker's IPO Tests a Slumping Biotech Market

Chinese Drugmaker's IPO Tests a Slumping Biotech Market


Innovent Biologics is going public despite shares of three Chinese biotech firms plunging following recent listing debuts in Hong Kong A Chinese cancer drug developer is pushing ahead with an initial public offering in Hong Kong, despite a global markets rout and the recent poor performance of other biotechnology startups that have listed in the city. Innovent Biologics Inc., a company that has partnered with Eli Lilly & Co.



from Biotech News
Share:

USANA Health Sciences, Inc. (USNA) Holdings Trimmed by Schroder Investment Management Group

USANA Health Sciences, Inc. (USNA) Holdings Trimmed by Schroder Investment Management Group


Schroder Investment Management Group lessened its holdings in shares of USANA Health Sciences, Inc. by 58.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 138,694 shares of the company's stock after selling 194,364 shares during the quarter.



from Biotech News
Share:

Novo Nordisk picks AstraZeneca executive to head biopharma business

Novo Nordisk picks AstraZeneca executive to head biopharma business


Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been struggling with declining sales and a failed acquisition. COPENHAGEN: Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been struggling with declining sales and a failed acquisition.



from Biotech News
Share:

NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis

NIH Awards Allele with Grant for the Development of Nanoantibody Therapies for Treating Sepsis


Oct 15, 2018--The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis. Sepsis and septic shock are among the leading causes of death in intensive care units .



from Biotech News
Share:

Stat | Pharmalot Vertex also faces a drug-price fight in Canada

Stat | Pharmalot Vertex also faces a drug-price fight in Canada


Yet another country has begun battling with Vertex Pharmaceuticals over its cystic fibrosis medicines. In a new report, an independent Canadian advisory group has rejected the use of the company's Orkambi treatment over questions about both its cost and clinical effectiveness.



from Biotech News
Share:

Brokerages Set Connect Group PLC (CNCT) PT at $111.33

Brokerages Set Connect Group PLC (CNCT) PT at $111.33


Shares of Connect Group PLC have been assigned a consensus rating of "Buy" from the six ratings firms that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company.



from Biotech News
Share:

Analyzing Natural Health Trends

Analyzing Natural Health Trends


Natural Health Trends and Central Garden & Pet are both small-cap consumer discretionary companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation. This is a summary of recent recommendations and price targets for Natural Health Trends and Central Garden & Pet, as reported by MarketBeat.com.



from Biotech News
Share:

Sandoz beendet Patentstreit um Biosimilar Adalimumab mit AbbVie

Sandoz beendet Patentstreit um Biosimilar Adalimumab mit AbbVie


(dpa-AFX) Die Novartis-Tochter Sandoz hat alle Rechtsstreitigkeiten mit dem amerikanischen Pharmaunternehmen Abbvie in Bezug auf das Biosimilar Adalimumab (Hyrimoz) für das Referenzmedikament Humira weltweit beigelegt. Im Rahmen der Vereinbarung gewähre AbbVie Sandoz eine nicht-exklusive Lizenz für ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Die Tage von Stada an der Börse sind gezählt

Die Tage von Stada an der Börse sind gezählt


(dpa) Die mit rund 65 Prozent dominierenden Finanzinvestoren Bain und Cinven machen den übrigen Aktionären wie angekündigt ein öffentliches Angebot zum Erwerb ihrer Anteile. Je Stada-Aktie wird eine Zahlung von 81,73 Euro offeriert, wie aus den am Donnerstag veröffentlichten Unterlagen hervorgeht. D...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Wie sich Superbugs schnell entwickeln

Wie sich Superbugs schnell entwickeln


Ein wissenschaftlicher Durchbruch hat eine neue Art der Bakterienentwicklung aufgedeckt, die mindestens 1.000 mal effizienter sein soll als jeder derzeit bekannte Mechanismus. Die Erkenntnisse werden den Wissenschaftlern helfen, besser zu verstehen, wie sich Superbugs schnell entwickeln und zunehmen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Kenne deinen Feind

Kenne deinen Feind


image description
Um deine Feinde zu bekämpfen, hilft es, ihre Schwächen zu kennen. Und je spezifischer dein Wissen, desto leichter ist es, ihre Verteidigung zu untergraben. Wenn dein Feind zum Beispiel sicher hinter einer riesigen Mauer sitzt, ist es wertvoll zu wissen, wie dein Feind sie gebaut hat, welche Material...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

15 neue Technologien, die die globalen katastrophalen biologischen Risiken reduzieren könnten

15 neue Technologien, die die globalen katastrophalen biologischen Risiken reduzieren könnten


image description
Strategische Investitionen in 15 vielversprechende Technologien könnten dazu beitragen, die Welt besser vorzubereiten und auszurüsten, damit künftige Ausbrüche von Infektionskrankheiten nicht zu katastrophalen Ereignissen werden.Diese Teilmenge neuer Technologien und deren potenzielle Anwendung steh...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Will Bayer Geschäft mit Tiergesundheit verkaufen?

Will Bayer Geschäft mit Tiergesundheit verkaufen?


(dpa-AFX) Bayer denkt Kreisen zufolge über eine Trennung vom Geschäft mit Tiergesundheit nach. Die Prüfung sei Teil einer größeren Überprüfung nach der 63 Milliarden Dollar schweren Übernahme des US-Saatgutkonzerns Monsanto, berichtete die Nachrichtenagentur Bloomberg am Mittwoch unter Berufung auf ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis kommt mit MS-Mittel voran

Novartis kommt mit MS-Mittel voran


(dpa-AFX) Novartis kommt mit seinem MS-Mittel Siponimod voran. Sowohl die US-Behörde FDA als auch ihr europäisches Gegenstück EMA haben den Zulassungsantrag angenommen, wie der Pharmakonzern am Montag in Basel mitteilte. Das Novartis-Mittel ist demnach das erste und einzige, das eine bedeutsame Verz...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

MannKind (MNKD) Trading 5.3% Higher

MannKind (MNKD) Trading 5.3% Higher


MannKind Co. 's share price traded up 5.3% during trading on Friday . The company traded as high as $1.61 and last traded at $1.60.



from Biotech News
Share:

MAI Capital Management Sells 534 Shares of Amgen, Inc.

MAI Capital Management Sells 534 Shares of Amgen, Inc.


MAI Capital Management lessened its holdings in Amgen, Inc. by 0.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 72,445 shares of the medical research company's stock after selling 534 shares during the quarter.



from Biotech News
Share:

154,801 Shares in Johnson & Johnson (JNJ) Purchased by Pwmco LLC

154,801 Shares in Johnson & Johnson (JNJ) Purchased by Pwmco LLC


Pwmco LLC bought a new stake in Johnson & Johnson during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission . The institutional investor bought 154,801 shares of the company's stock, valued at approximately $18,784,000.



from Biotech News
Share:

Comparing Thyssenkrupp Ag/S

Comparing Thyssenkrupp Ag/S


THYSSENKRUPP AG/S and Eisai are both large-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. 0.1% of Eisai shares are held by institutional investors.



from Biotech News
Share:

Merck & Co., Inc. (MRK) Price Target Raised to $78.00 at Barclays

Merck & Co., Inc. (MRK) Price Target Raised to $78.00 at Barclays


The firm currently has an "overweight" rating on the stock. Barclays' price target indicates a potential upside of 11.73% from the company's previous close.



from Biotech News
Share:

Douglass Winthrop Advisors LLC Has $1.93 Million Holdings in Novartis AG

Douglass Winthrop Advisors LLC Has $1.93 Million Holdings in Novartis AG


Douglass Winthrop Advisors LLC cut its position in shares of Novartis AG by 33.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,395 shares of the company's stock after selling 11,250 shares during the quarter.



from Biotech News
Share:

Canton Hathaway LLC Purchases New Holdings in Seattle Genetics, Inc.

Canton Hathaway LLC Purchases New Holdings in Seattle Genetics, Inc.


Canton Hathaway LLC purchased a new stake in Seattle Genetics, Inc. in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 33,840 shares of the biotechnology company's stock, valued at approximately $2,610,000.



from Biotech News
Share:

Insider Selling: Illumina, Inc. (ILMN) SVP Sells 10,000 Shares of Stock

Insider Selling: Illumina, Inc. (ILMN) SVP Sells 10,000 Shares of Stock


Illumina, Inc. SVP Mostafa Ronaghi sold 10,000 shares of the company's stock in a transaction dated Wednesday, October 10th. The shares were sold at an average price of $311.84, for a total transaction of $3,118,400.00.



from Biotech News
Share:

Lab to study impact of genetics, microbiome on substance use

Lab to study impact of genetics, microbiome on substance use


A Maine laboratory will receive nearly $4 million to study the role of the microbiome and genetics in substance use disorders. The human microbiome is the full assortment of bacteria, viruses and other microbes than inhabits the human body.



from Biotech News
Share:

Ellen McCarthy Joins Polaris as Vice President of Government Affairs

Ellen McCarthy Joins Polaris as Vice President of Government Affairs


Oct 12, 2018--Polaris Industries Inc. today announced that Nancy "Ellen" McCarthy joins Polaris as vice president of Government Affairs effective immediately, reporting to Lucy Clark Dougherty, senior vice president, general counsel, compliance officer and corporate secretary. "We are thrilled to welcome Ellen to Polaris.



from Biotech News
Share:

Retailers up their game after Toys R Us closures

Retailers up their game after Toys R Us closures


Walmart says 30 percent of its holiday toy assortment will be new. It will also offer 40 p... .



from Biotech News
Share:

UPDATE 1-U.S. appeals court upholds ruling that canceled Teva Copaxone patents

UPDATE 1-U.S. appeals court upholds ruling that canceled Teva Copaxone patents


A U.S. appeals court on Friday upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd on its blockbuster multiple sclerosis drug Copaxone. The ruling was a victory for a group of generic drug companies, including Mylan NV and Novartis AG unit Sandoz, that challenged the validity of Teva's patents in order to sell generic versions.



from Biotech News
Share:

State of Alaska Department of Revenue Sells 537 Shares of Illumina, Inc.

State of Alaska Department of Revenue Sells 537 Shares of Illumina, Inc.


State of Alaska Department of Revenue reduced its position in Illumina, Inc. by 2.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 23,260 shares of the life sciences company's stock after selling 537 shares during the quarter.



from Biotech News
Share:

Bristol-Myers' Opdivo fails to meet lung cancer study goal

Bristol-Myers' Opdivo fails to meet lung cancer study goal


Bristol-Myers Squibb Co said on Friday its blockbuster cancer drug Opdivo failed to meet the main goal in patients with a type of lung cancer, that had relapsed after chemotherapy. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headquarters in Le Passage, near Agen, France March 29, 2018.



from Biotech News
Share:

Pfizer settles New York probe into 'deceptive' copay coupons

Pfizer settles New York probe into 'deceptive' copay coupons


Pfizer Inc on Thursday settled charges by New York's attorney general that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than they ended up having to shell out. The Pfizer logo is seen at their world headquarters in New York April 28, 2014.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Lohr Vineyards & Wines is proud to announce the 10-year anniversary of its nationwide Touching Lives campaign, which has made a measurable difference in ma... )--Regulatory News: Plant Advanced Technologies PAT annonces that Temisis, its subsidiary dedicated to the development of anti-inflammatory ... )--Regulatory News: Plant Advanced Technologies PAT annonce que Temisis, sa filiale de dA©veloppement d'actifs anti-inflammatoires, fait part... )--ITRenew, Inc. de la Silicon Valley a annoncA© la finalisation de son acquisition d'ESISO, LLC , un chef de file de l'industrie du reconditionnem... )--Qordoba, the world's first UX content management platform, announced today Series B funding of $11.5 million, led by Aspect Ventures.



from Biotech News
Share:

Finanzen: Gesetzliche Rentenversicherung : Gesetzliche Rentenversicherung

Die gesetzliche Rente ist für die meisten im Alter unverzichtbar. Wir erklären, wie sie funktioniert, wie hoch sie ausfällt und warum das Rentenniveau sinken wird.

from Finanztip Feed
Supported by Video Collection
Share:

-$0.30 EPS Expected for Intec Pharma (NTEC) This Quarter

-$0.30 EPS Expected for Intec Pharma (NTEC) This Quarter


Wall Street brokerages expect that Intec Pharma will post earnings of per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Intec Pharma's earnings.



from Biotech News
Share:

Thousands of young US children get no vaccines, survey finds

Thousands of young US children get no vaccines, survey finds


This 1981 electron microscope image made available by the Centers for Disease Control and Prevention shows varicella-zoster virions from a patient with chickenpox. On Thursday, Oct. 11, 2018, the CDC says a small but growing proportion of U.S. toddlers have not been vaccinated against any disease.



from Biotech News
Share:

Finanzen: Fernwärme : Fernwärme

Fernwärme ist bequem, sauber – und teuer. Mangels Wettbewerbs müssen Verbraucher hohe Preise hinnehmen. Sparpotenzial gibt es aber, wenn Sie die Anschlussleistung prüfen lassen.

from Finanztip Feed
Supported by Video Collection
Share:

Sandoz beendet Patentstreit um Biosimilar Adalimumab mit AbbVie

Sandoz beendet Patentstreit um Biosimilar Adalimumab mit AbbVie


(dpa-AFX) Die Novartis-Tochter Sandoz hat alle Rechtsstreitigkeiten mit dem amerikanischen Pharmaunternehmen Abbvie in Bezug auf das Biosimilar Adalimumab (Hyrimoz) für das Referenzmedikament Humira weltweit beigelegt. Im Rahmen der Vereinbarung gewähre AbbVie Sandoz eine nicht-exklusive Lizenz für ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Die Tage von Stada an der Börse sind gezählt

Die Tage von Stada an der Börse sind gezählt


(dpa) Die mit rund 65 Prozent dominierenden Finanzinvestoren Bain und Cinven machen den übrigen Aktionären wie angekündigt ein öffentliches Angebot zum Erwerb ihrer Anteile. Je Stada-Aktie wird eine Zahlung von 81,73 Euro offeriert, wie aus den am Donnerstag veröffentlichten Unterlagen hervorgeht. D...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Man Charged for Alleged Fentanyl Sale in La Jolla Man's Death

Man Charged for Alleged Fentanyl Sale in La Jolla Man's Death


MARCH 23: Oxycodone pain pills prescribed for a patient with chronic pain lie on display on March 23, 2016 in Norwich, CT. Communities nationwide are struggling with the unprecidented opioid pain pill and heroin addiction epidemic.



from Biotech News
Share:

New Haven Biotech Goes Public and Execs Buy In With The Public

New Haven Biotech Goes Public and Execs Buy In With The Public


NEW HAVEN: A city biotech based on technology of Yale researcher Craig Crews has taken to the public markets with an Initial Public Offering on September 27. Arvinas, Inc . [Nasdaq: ARVN], the company's CEO, Chairman and other key executives have made significant stock purchases in the open market.



from Biotech News
Share:

Wie sich Superbugs schnell entwickeln

Wie sich Superbugs schnell entwickeln


Ein wissenschaftlicher Durchbruch hat eine neue Art der Bakterienentwicklung aufgedeckt, die mindestens 1.000 mal effizienter sein soll als jeder derzeit bekannte Mechanismus. Die Erkenntnisse werden den Wissenschaftlern helfen, besser zu verstehen, wie sich Superbugs schnell entwickeln und zunehmen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's...

The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's...


Crispr Therapeutics AG and Vertex Pharmaceuticals Incorporated said the FDA has lifted the clinical hold and accepted the investigational new drug application, or IND, for CTX001, their gene-edited hematopoietic stem-cell therapy for treating sickle cell disease, or SCD. The companies said they have already obtained approvals of Clinical Trial Applications for CTX001 in multiple countries outside the U.S. for both beta-thalassemia and SCD.



from Biotech News
Share:

As China Hunts For New Cures, Investors Flood U.S. Biotech Firms With Cash

As China Hunts For New Cures, Investors Flood U.S. Biotech Firms With Cash


A researcher prepares samples inside a laboratory at BeiGene Ltd.'s research and development center in Beijing, China, on Thursday, May 24, 2018. Chinese investors are putting record amounts of money into U.S.-based biotechnology firms as Beijing seeks to become a powerhouse in developing new medicines, but the investment rush is also fueling concerns that valuations are being pushed to unsustainable levels.



from Biotech News
Share:

Investors Buy Shares of SPDR S&P Biotech Etf (Xbi) on Weakness

Investors Buy Shares of SPDR S&P Biotech Etf (Xbi) on Weakness


Investors bought shares of SPDR S&P Biotech ETF on weakness during trading on Wednesday. $147.17 million flowed into the stock on the tick-up and $108.17 million flowed out of the stock on the tick-down, for a money net flow of $39.00 million into the stock.



from Biotech News
Share:

Finanzen: Lebensversicherung verkaufen : Lebensversicherung verkaufen

Der Verkauf einer Lebensversicherung bringt meist mehr als das Kündigen. Prüfen Sie aber, ob es sich nicht doch lohnt, den Vertrag fortzuführen.

from Finanztip Feed
Supported by Video Collection
Share:

Is Mylan CEO Heather Bresch the Daughter of W.V. Democratic Senator Joe Manchin?

Is Mylan CEO Heather Bresch the Daughter of W.V. Democratic Senator Joe Manchin?


A meme about Manchin's vote to confirm Kavanaugh accurately notes that Heather Bresch is Manchin's daughter, but it's not clear why that's relevant. In early October 2018, social media users shared a meme bearing a critical message about Sen. Joe Manchin, the lone Democrat who voted to confirm U.S. Supreme Court Justice Brett Kavanaugh, and his daughter, Mylan CEO Heather Bresch: It's no secret Bresch is the daughter of the U.S. senator from West Virginia, and that father and daughter were the subjects of two very different and unrelated controversies.



from Biotech News
Share:

Finding answers for patients with rarest of rare diseases

Finding answers for patients with rarest of rare diseases


Patients whose mysterious symptoms have stumped other experts are getting a new chance at diagnosis through a network of hospitals that tackles the rarest of rare diseases. It's called the Undiagnosed Diseases Network, set up by the National Institutes of Health.



from Biotech News
Share:

Lexicon Pharmaceuticals, Inc. (LXRX) Expected to Post Quarterly Sales of $13.23 Million

Lexicon Pharmaceuticals, Inc. (LXRX) Expected to Post Quarterly Sales of $13.23 Million


Analysts expect that Lexicon Pharmaceuticals, Inc. will report $13.23 million in sales for the current quarter, according to Zacks . Three analysts have made estimates for Lexicon Pharmaceuticals' earnings.



from Biotech News
Share:

Bayer gets tentative ruling for new trial in weed-killer case

Bayer gets tentative ruling for new trial in weed-killer case


Bayer AG's Monsanto unit will get a new trial on the US$250 million in punitive damages awarded by a jury to a groundskeeper who alleged the company's glyphosate-based weed killers, including Roundup, gave him cancer. FILE PHOTO: Monsanto's Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium, November 27, 2017.



from Biotech News
Share:

Will Bayer Geschäft mit Tiergesundheit verkaufen?

Will Bayer Geschäft mit Tiergesundheit verkaufen?


(dpa-AFX) Bayer denkt Kreisen zufolge über eine Trennung vom Geschäft mit Tiergesundheit nach. Die Prüfung sei Teil einer größeren Überprüfung nach der 63 Milliarden Dollar schweren Übernahme des US-Saatgutkonzerns Monsanto, berichtete die Nachrichtenagentur Bloomberg am Mittwoch unter Berufung auf ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Bayer gets new trial on punitive damages in $289 mln weed-killer case

Bayer gets new trial on punitive damages in $289 mln weed-killer case


Bayer AG's Monsanto unit has received a tentative ruling granting a new trial on the $250 million in punitive damages awarded by a jury to a groundskeeper who alleged the company's glyphosate-based weed killers, including Roundup, gave him cancer. According to Wednesday court filings in San Francisco's Superior Court of California, Judge Suzanne Bolanos was considering whether to grant the company's motion for a new trial on punitive damages.



from Biotech News
Share:

FDA lifts hold on first-ever CRISPR/Cas9 gene-editing trial

FDA lifts hold on first-ever CRISPR/Cas9 gene-editing trial


The FDA lifted its hold on CRISPR Therapeutics and Vertex Pharmaceuticals' highly anticipated gene-editing trial Wednesday, allowing the first company-backed trial using the CRISPR/Cas9 technology to start in the U.S. CRISPR and Vertex were preparing to test the the ability of a new gene-editing technology, CRISPR/Cas9, in cutting out and replacing disease-causing snippets of DNA when the FDA placed the hold in May. The trial is scheduled to start by the end of 2018, according to a joint statement from the companies. The experimental technology has not yet been tested in humans and has raised safety concerns in the industry.



from Biotech News
Share:

This Chinese Penny Stock Could Have 600% Upside

This Chinese Penny Stock Could Have 600% Upside


Everyone knows the risks of investing in penny stocks , but there's no denying they can also create life-changing wealth. On Sept.



from Biotech News
Share:

15 neue Technologien, die die globalen katastrophalen biologischen Risiken reduzieren könnten

15 neue Technologien, die die globalen katastrophalen biologischen Risiken reduzieren könnten


image description
Strategische Investitionen in 15 vielversprechende Technologien könnten dazu beitragen, die Welt besser vorzubereiten und auszurüsten, damit künftige Ausbrüche von Infektionskrankheiten nicht zu katastrophalen Ereignissen werden.Diese Teilmenge neuer Technologien und deren potenzielle Anwendung steh...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Kenne deinen Feind

Kenne deinen Feind


image description
Um deine Feinde zu bekämpfen, hilft es, ihre Schwächen zu kennen. Und je spezifischer dein Wissen, desto leichter ist es, ihre Verteidigung zu untergraben. Wenn dein Feind zum Beispiel sicher hinter einer riesigen Mauer sitzt, ist es wertvoll zu wissen, wie dein Feind sie gebaut hat, welche Material...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Delaware Chancery Court Finally Finds an MAE

Delaware Chancery Court Finally Finds an MAE


The Situation : In a significant decision, a Delaware court found that a target company has suffered a material adverse effect , allowing a would-be buyer to abandon an announced merger. The Case : In Akorn, Inc. v.



from Biotech News
Share: